ଚିକିତ୍ସା ସମୟରେ ପାଟିରେ ଘା'

The goal of this phase II, single-arm interventional clinical trial is to evaluate whether oral sodium copper chlorophyllin (CHL) can reduce the frequency and severity of oral mucositis in patients aged 12-65 years undergoing myeloablative total body irradiation (TBI) as part of conditioning before their first allogeneic Hematopoietic Stem Cell Transplantation (HSCT). The main questions it aims to answer are: Does oral chlorophyllin reduce the incidence of Grade III and IV oral mucositis by day +28 after HSCT? Does oral chlorophyllin reduce the duration of severe oral mucositis and the need …

ସ୍ପୋନ୍ସର: ଟାଟା ମେମୋରିଆଲ୍ ସେଣ୍ଟର
ClinicalTrials.gov ରେ NCT07709195
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ୍ 27 ଜୁଲାଇ 2026 · ଆମେ ପଢିଲୁ 20 ଅକ୍ଟୋବର 2026